Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-98,597
Closed -$790K 1778
2024
Q2
$790K Buy
98,597
+52,294
+113% +$467K 0.02% 929
2024
Q1
$539K Buy
+46,303
New +$513K 0.01% 1139
2023
Q2
Sell
-37,675
Closed -$574K 1900
2023
Q1
$574K Sell
37,675
-1,107
-3% -$14.4K 0.02% 829
2022
Q4
$494K Buy
+38,782
New +$349K 0.03% 781
2022
Q2
Sell
-16,700
Closed -$63K 1733
2022
Q1
$63K Buy
+16,700
New +$108K ﹤0.01% 1454

Other funds holding ETNB

Jump Financial's ETNB Position: Q3 2024 in Review

Jump Financial sold out of 89bio (ETNB) in Q3 2024, closing a stake of 98,597 shares — an estimated $790K sold.

Jump Financial first reported a position in ETNB in Q1 2022 and held it in 5 quarters. The position peaked at $790K in Q2 2024. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Jump Financial reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 98,597 89bio shares in Q3 2024, an estimated $790K.
  • Jump Financial first reported a position in 89bio in Q1 2022 and held it in 5 quarters.
  • Jump Financial's 89bio position peaked at $790K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.